Detailed Guide Coming Soon
We're working on a comprehensive educational guide for the GLP-1 Monthly Cost Calculator in your language. The content below is shown in English.
What is GLP-1 Monthly Cost Calculator?
▾
Managing corporate healthcare expenditures requires a precise understanding of pharmacy benefit design, particularly with the explosive rise of glucagon-like peptide-1 (GLP-1) receptor agonists. For CFOs, human resource executives, and benefits consultants, GLP-1 medications represent both a highly demanded employee benefit and a significant line-item financial risk. This calculator delivers a rigorous financial modeling framework to project the actual net cash outlay for these treatments, cutting through the noise of deceptive wholesale acquisition costs (WAC) to reveal true, contract-adjusted monthly costs. The financial landscape of GLP-1 drugs is characterized by extreme price dispersion driven by therapeutic indication (e.g., type 2 diabetes vs. chronic weight management), formulary tiering, copay card dynamics, and employer plan design. For instance, the same active ingredient (semaglutide) is commercialized under different brand names and pricing structures depending on the clinical pathway. This tool allows corporate treasury and benefits planning teams to model these variables accurately, shifting from speculative estimating to precise, data-driven budgeting. Ultimately, this calculator serves as an essential decision-support tool for corporate wellness ROI analysis. By quantifying out-of-pocket costs across various plan configurations—including high-deductible health plans (HDHPs), preferred provider organizations (PPOs), and self-funded arrangements—organizations can optimize their pharmacy benefit manager (PBM) negotiations, design equitable cost-sharing strategies, and forecast the long-term fiscal impact of obesity management benefits on their bottom line.
Calkulon makes complex calculations simple — built for students and everyday problem-solvers.
Formula
▾
Monthly Out-of-Pocket Cost = max((List Price - Insurance Paid Amount - Manufacturer Savings Program Discount), Minimum Copay Floor), where Insurance Paid Amount = List Price x (1 - Coinsurance Rate) after the annual deductible has been met, or Insurance Paid Amount = 0 if the deductible has not been met or the drug is not covered.Variable Legend
▾
| Symbol | Vārds | Vienība | Apraksts |
|---|---|---|---|
| Plist | List Price | USD per month | The Wholesale Acquisition Cost (WAC) or baseline MSRP set by the manufacturer before any commercial discounts, rebates, or pharmacy-specific markups are applied. |
| Cins | Insurance Coverage Amount | USD per month | The financial portion of the medication cost absorbed by the employer's health plan once deductible criteria have been satisfied. |
| r | Coinsurance Rate | percentage | The contractually mandated percentage of the medication cost that is the financial responsibility of the employee (typically 20% to 40% for specialty tiers). |
| Smfg | Manufacturer Savings Discount | USD per fill | The dollar discount provided by pharmaceutical manufacturer copay cards, designed to offset employee out-of-pocket liabilities. |
| D | Annual Deductible | USD per year | The annual threshold of out-of-pocket expenses an employee must personally satisfy before insurance-tier cost-sharing is activated. |
| OOPmax | Out-of-Pocket Maximum | USD per year | The regulatory or contractual maximum limit an employee can pay in a calendar year, after which the plan covers 100% of eligible costs. |
How to GLP-1 Monthly Cost Calculator
▾
- 1Select the target therapeutic agent and dosage. The database tracks current commercial list prices (WAC) for industry-standard GLP-1 brands like Wegovy, Ozempic, Mounjaro, and Zepbound, alongside emerging compounded alternatives.
- 2Define the corporate insurance plan archetype and formulary status. Specify if the plan is a commercial self-insured PPO, high-deductible health plan (HDHP), or government-sponsored program, noting the medication's tier level.
- 3Establish the deductible parameters. Input the annual individual deductible limit and the year-to-date accumulation to accurately model when the plan transitions from the deductible phase to the coinsurance phase.
- 4Factor in manufacturer-sponsored copay assistance programs. The calculator applies maximum monthly and annual limits from major pharmaceutical manufacturers (e.g., Eli Lilly, Novo Nordisk) based on commercial coverage status.
- 5Select the distribution channel. Compare cost structures between retail networks, mail-order programs, and specialized contract pharmacies, which often feature distinct negotiated discount structures.
- 6Analyze the monthly and annualized cost projection. Review the detailed cash-flow breakdown, which highlights the exact month the deductible is satisfied, the timing of out-of-pocket maximum thresholds, and any potential cost cliffs.
- 7Conduct a scenario analysis. Use the side-by-side comparison matrix to evaluate alternative formulations or therapeutic substitutions to determine the most cost-effective formulary strategy for your workforce.
Worked Examples
▾
With a $1,349 list price and an unmet $3,000 deductible, the patient initially pays the full list price minus the savings card's maximum monthly benefit of $225 (netting $1,124). By month 3, the remaining deductible is satisfied, triggering 20% coinsurance ($269.80), which the savings card reduces to the $25 minimum copay floor. This illustrates the front-loaded cash flow profile typical of HDHP structures.
The medication is positioned on a preferred brand tier with a flat $50 copay. The manufacturer's savings card covers up to $150 of the copay, but is subject to a hard minimum floor of $25. Thus, the employee's net cost is capped at $25 per month, with the employer's self-funded plan absorbing the remaining $885 of the negotiated list price.
Because the employer's plan explicitly excludes weight-loss coverage, the insurance payment is $0. However, Eli Lilly offers a cash-paying savings card for commercially insured patients whose plans exclude coverage, providing a flat discount of approximately $510 off the $1,060 list price, resulting in a net monthly out-of-pocket cost of $550.
To manage benefits budgets, some employers contract directly with accredited compounding pharmacies during national drug shortages. Since these are non-branded preparations, they do not qualify for manufacturer coupons, but the raw cash cost is negotiated down to a flat $225 per month, bypassing insurance entirely and delivering a highly predictable cost profile.
Real-World Applications
▾
Corporate Benefits Budgeting & Plan Design: Corporate HR leaders and benefits brokers use this calculator to model the fiscal impact of adding GLP-1 coverage to self-insured plans. By analyzing various deductible and coinsurance scenarios, they can structure plans that balance employee retention with sustainable healthcare spend.
CFO Financial Forecasting: CFOs and corporate treasurers utilize monthly cost modeling to project quarterly cash flows. Because GLP-1 adoption rates are highly predictable once started, modeling these costs allows for accurate accrual accounting and premium adjustment forecasts.
PBM Contract Negotiations: Procurement and finance teams use these calculations to stress-test Pharmacy Benefit Manager (PBM) proposals. Understanding the gap between list prices, copay card dynamics, and net plan costs empowers negotiators to demand better rebate pass-through structures.
ROI Modeling for Employee Wellness Initiatives: Health economists and corporate wellness directors use the output to calculate the return on investment of obesity management programs. By comparing the net annualized cost of GLP-1s against projected reductions in secondary claims (such as cardiovascular events or musculoskeletal surgeries), they can build a clear business case.
Special Cases
▾
Corporate Mergers and Benefit Plan Harmonization
During corporate acquisitions, employees often transition between different PBMs and plan designs mid-year. This transition can reset deductibles and out-of-pocket maximums, creating unexpected double-deductible exposures that must be modeled to prevent employee dissatisfaction and budget overruns.
Self-Insured Employers with Stop-Loss Insurance Coverage
For self-insured firms, high-cost GLP-1 utilization can quickly trigger stop-loss insurance thresholds. Understanding individual employee monthly cost curves helps risk managers forecast when stop-loss reimbursements will kick in, protecting corporate cash reserves.
Expatriate and Global Workforce Coverage
Multinational corporations face highly fragmented pricing structures across regions. While US employees face high list prices and complex coupon systems, European or Canadian employees operate under regulated price caps, requiring distinct regional benefits budgeting strategies.
GLP-1 Medication List Prices and Typical Corporate Costs (2025)
▾
| Therapeutic Agent | Monthly List Price (WAC) | Typical Employer Plan Cost (Net) | Employee Cost with Savings Card | Compounded Market Alternative |
|---|---|---|---|---|
| Wegovy (semaglutide 2.4 mg) | $1,349 | $950 - $1,150 | $0 - $25 | N/A |
| Ozempic (semaglutide 2.0 mg) | $935 | $650 - $800 | $0 - $25 | N/A |
| Mounjaro (tirzepatide 15 mg) | $1,023 | $700 - $850 | $0 - $25 | N/A |
| Zepbound (tirzepatide 15 mg) | $1,060 | $750 - $900 | $0 - $25 | N/A |
| Saxenda (liraglutide 3.0 mg) | $1,349 | $1,000 - $1,200 | $25 - $50 | N/A |
| Compounded Semaglutide | N/A | Not Covered (Standard) | N/A | $150 - $300 |
Frequently Asked Questions
▾
How much does Ozempic cost without insurance?
The list price for Ozempic is approximately $935-$1,000 per month (as of 2024). Without insurance, patients can check Novo Nordisk patient assistance programs or compounding pharmacy alternatives. Some patients use manufacturer savings cards to reduce costs to $25-$150/month if eligible.
Does Medicare cover GLP-1 medications for weight loss?
As of 2025, Medicare Part D began covering anti-obesity medications including semaglutide for weight management following the TREAT Act provisions. Previously, Medicare only covered GLP-1 drugs for diabetes indications. Check your specific Part D plan formulary for tier placement and copay amounts.
Are GLP-1 medications cheaper in Canada or Mexico?
Yes, GLP-1 medications are often 40-70% cheaper in Canada and Mexico compared to US list prices. However, importing prescription medications carries legal and safety considerations. Always verify the pharmacy is licensed and the medication is genuine.
Common Mistakes to Avoid
▾
- !Confusing clinical efficacy with fiscal alignment by assuming that because a drug is highly effective, it will automatically be covered under standard corporate wellness plans. Many plans explicitly exclude obesity treatments, leading to massive budget variances.
- !Ignoring the 'Accumulator' and 'Maximizer' clauses in corporate health plans, which prevent manufacturer coupon values from counting toward the employee's deductible, delaying the transition to full plan coverage.
- !Failing to model the 'Manufacturer Coupon Cliff' by assuming the low introductory copay of $25 will persist indefinitely, ignoring the annual caps and 12-month expiration terms built into manufacturer assistance programs.
Pro Tip
When auditing your corporate health plan's GLP-1 spend, demand a 'net-of-rebate' report from your Pharmacy Benefit Manager (PBM). PBMs often hide the true cost of these drugs behind high list prices while retaining a significant portion of the manufacturer rebates; securing full rebate pass-through can reduce your organization's net GLP-1 liability by up to 30%.
Did you know?
The macroeconomic impact of GLP-1 medications is so profound that in 2024, Denmark’s central bank had to adjust its national interest rate forecasts and currency interventions. This was driven entirely by the massive export revenues of Novo Nordisk (maker of Ozempic and Wegovy), illustrating how a single pharmaceutical class can reshape a nation's sovereign financial policy.
Regional Guides
▾
United States▾
European Union and United Kingdom▾
Canada and Mexico▾
References
Saņemiet iknedēļas matemātikas padomus
Pievienojieties 12 000+ abonentiem, kuri katru nedēļu saņem kalkulatora padomus.